# Opsona Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/opsona-therapeutics

- Industry: Biotechnology
- Headquarters: Dublin, Ireland
- Website: www.opsona.com
- Total disclosed funding: $92M
- Latest round: Series C (Oct 2, 2013)
- Investors on record: 13

## About

Opsona Therapeutics is a biotechnology company focused on novel therapeutic and preventative approaches to autoimmune and inflammatory diseases.

## Funding rounds

- Series C, Oct 2, 2013, $4.1M — Omnes Capital
- Series C, Oct 2, 2013, $4.1M — EMBL Ventures, Novartis Venture Fund, Omnes Capital, BB Biotech, Heartcore Capital, Fountain Healthcare Partners, Roche Venture Fund
- Series C, Apr 29, 2013, $43M — EMBL Ventures, Novartis Venture Fund, Seroba, Amgen Ventures, BB Biotech, Heartcore Capital, Fountain Healthcare Partners, Roche Venture Fund, Baxter Ventures
- Series B, Jun 15, 2009, $4.6M — Inventages Venture Capital, Novartis Venture Fund, Seroba, Fountain Healthcare Partners, Enterprise Ireland, Roche Venture Fund
- Series B, May 19, 2009, $4.5M — Inventages Venture Capital, Novartis Venture Fund, Seroba, Fountain Healthcare Partners, Enterprise Ireland, Roche Venture Fund
- Series B, Feb 18, 2009, $23M — Inventages Venture Capital, Novartis Venture Fund, Seroba, Fountain Healthcare Partners
- Series A, Feb 24, 2005, $8.6M — Inventages Venture Capital, Seroba, Enterprise Ireland, Genentech, Inc.

## Investors

- Inventages Venture Capital (https://capitalatlas.ai/funds/inventages-venture-capital) — Series A, Series B
- Seroba (https://capitalatlas.ai/funds/seroba) — Series A, Series B, Series C
- Enterprise Ireland (https://capitalatlas.ai/funds/enterprise-ireland) — Series A, Series B
- Genentech, Inc. — Series A
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series B, Series C
- Fountain Healthcare Partners (https://capitalatlas.ai/funds/fountain-healthcare-partners) — Series B, Series C
- Roche Venture Fund (https://capitalatlas.ai/funds/roche-venture-fund) — Series B, Series C
- EMBL Ventures (https://capitalatlas.ai/funds/embl-ventures) — Series C
- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series C
- BB Biotech (https://capitalatlas.ai/funds/bb-biotech) — Series C
- Heartcore Capital (https://capitalatlas.ai/funds/heartcore-capital) — Series C
- Baxter Ventures (https://capitalatlas.ai/funds/baxter-ventures) — Series C
- Omnes Capital (https://capitalatlas.ai/funds/omnes-capital) — Series C